tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VIR Stock Latest News

Vir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating
RatingsVir Biotechnology: Strengthening Best-in-Class HDV Profile with Robust SOLSTICE Data, Strategic Partnerships, and Sufficient Cash Runway Supporting Buy Rating
16d ago
VIR
H.C. Wainwright says Vir’s SOLSTICE 96-week data reinforces best-in-class
PremiumThe Fly
H.C. Wainwright says Vir’s SOLSTICE 96-week data reinforces best-in-class
16d ago
VIR
GILD
Vir Biotechnology updates on chronic hepatitis delta and oncology programs
PremiumThe Fly
Vir Biotechnology updates on chronic hepatitis delta and oncology programs
16d ago
VIR
Vir Biotechnology advances hepatitis delta program and cash runway
PremiumCompany Announcements
Vir Biotechnology advances hepatitis delta program and cash runway
17d ago
8K
VIR
Vir Biotechnology price target lowered to $13 from $14 at BofA
PremiumThe Fly
Vir Biotechnology price target lowered to $13 from $14 at BofA
23d ago
VIR
Unusually active option classes on open January 6th
PremiumThe FlyUnusually active option classes on open January 6th
23d ago
CVX
IRE
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
30d ago
VIR
EVMN
Vir Biotechnology: Norgine Partnership Extends Cash Runway and De‑Risks HDV Franchise, Supporting Buy Rating and $15 Target
Premium
Ratings
Vir Biotechnology: Norgine Partnership Extends Cash Runway and De‑Risks HDV Franchise, Supporting Buy Rating and $15 Target
30d ago
VIR
Vir Biotechnology: Strong HDV Performance and Strategic Partnership Drive Buy Rating
PremiumRatings
Vir Biotechnology: Strong HDV Performance and Strategic Partnership Drive Buy Rating
1M ago
VIR
Strategic Partnership Enhances Vir Biotechnology’s Financial Outlook and European Market Opportunities
PremiumRatings
Strategic Partnership Enhances Vir Biotechnology’s Financial Outlook and European Market Opportunities
1M ago
VIR
Closing Bell Movers: Lennar slips 4% after Q4 miss
PremiumThe Fly
Closing Bell Movers: Lennar slips 4% after Q4 miss
1M ago
DRS
LEN
Vir Biotechnology Secures Licensing Deal with Norgine
PremiumCompany Announcements
Vir Biotechnology Secures Licensing Deal with Norgine
1M ago
8K
VIR
Vir Biotechnology grants Norgine exclusive license to CHD treatment in Europe
PremiumThe FlyVir Biotechnology grants Norgine exclusive license to CHD treatment in Europe
1M ago
VIR
Mirum’s deal for Bluejay a positive readthrough to Vir, says Needham
Premium
The Fly
Mirum’s deal for Bluejay a positive readthrough to Vir, says Needham
2M ago
VIR
GILD
Vir Biotechnology’s HDV Program: A Promising Investment Opportunity Amidst Market Underappreciation
Premium
Ratings
Vir Biotechnology’s HDV Program: A Promising Investment Opportunity Amidst Market Underappreciation
2M ago
VIR
Vir Biotechnology announces Week 48 endpoint analysis of Phase 2 SOLSTICE
PremiumThe Fly
Vir Biotechnology announces Week 48 endpoint analysis of Phase 2 SOLSTICE
3M ago
VIR
Vir Biotechnology’s Earnings Call: Achievements and Challenges
PremiumCompany Announcements
Vir Biotechnology’s Earnings Call: Achievements and Challenges
3M ago
VIR
Positive Outlook for Vir Biotechnology: Buy Rating Driven by Promising Pipeline Developments and Strong Cash Position
PremiumRatings
Positive Outlook for Vir Biotechnology: Buy Rating Driven by Promising Pipeline Developments and Strong Cash Position
3M ago
VIR
3 Best Stocks to Buy Now, 11/6/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 11/6/2025, According to Top Analysts
3M ago
VIR
Vir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating
PremiumRatingsVir Biotechnology’s Strategic Advancements in HDV and Oncology Programs Justify Buy Rating
3M ago
VIR
Vir Biotechnology: Strong Financials and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
Vir Biotechnology: Strong Financials and Promising Clinical Developments Drive Buy Rating
3M ago
VIR
Vir Biotechnology Reports Q3 2025 Financial Results and Clinical Progress
Premium
Company Announcements
Vir Biotechnology Reports Q3 2025 Financial Results and Clinical Progress
3M ago
VIR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >